비보존 제약

082800KOSDAQ의약품 제조업

39.3 / 100

Reference Date: 2026-07-24

Financial Score5.0 / 40

News Sentiment21.3 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE is below the industry average, PBR raises overvaluation concerns. Declined 10.5% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Bibozen Pharmaceuticals is a specialized pharmaceutical company primarily engaged in the manufacturing and sales of prescription and over-the-counter drugs, offering a wide range of products including cardiovascular medications, diabetes treatments, and analgesics. The company operates over 190 product items through diverse business activities such as CMO, OEM, and international exports, while focusing on the research and development of innovative new drugs.

Number of Employees

292people

Average Salary

52.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 11.234.0Point

PBR

2.03Industry Average 0.810.0Point

2.5x industry avg (risky)

ROE

-36.21Industry Average 4.010.0Point

Well below industry avg

Debt Ratio

20.79Industry Average 12.430.5Point

1.7x industry avg (risky)

Trend 2023~20250.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼4.7% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼380.7% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -16.3% (declining, 3yr)

Detailed News Sentiment

5 totalPositive 5Neutral 0Negative 0Average Sentiment Score 85

Positive
"편의성 향상"…비보존제약, 알약 장정결제 출시
비보존제약의 새로운 알약형 장정결제 '라라팡정' 출시로 환자 편의성이 크게 향상되어 긍정적인 시장 반응 예상.
Positive
비보존제약, 복용편의성 높인 알약형 장정결제 ‘라라팡정’ 출시
비보존 제약의 새로운 알약형 장정결제 '라라팡정' 출시로 복용 편의성이 향상되어 임상적 효과와 안전성 검증 결과 긍정적 반응 예상.
Positive
비보존제약, 대장내시경 전처치제 ‘라라팡정’ 이달 말 출시
비보존제약의 새로운 알약형 장정결제 '라라팡정' 출시로 환자 편의성이 향상되어 긍정적인 시장 반응 예상.

Detailed Momentum

52-week position1.0Point

Near 52w low (4%, downtrend)

Current 2,435Won52-week high 7,74552-week low 2,180

1-month return1.0Point

1m -10.48% (falling)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-07-10
Neutral[기재정정]주식등의대량보유상황보고서(일반)2026-07-01
Neutral주식등의대량보유상황보고서(일반)2026-06-30